INTREPID (A randomized, double-blind, sham-controlled study of subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of individuals with Parkinson disease; NCT01839396)
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Epilepsy & Seizures
Functional Neurologic Symptom Disorder Resolving After Endoscopic Encephalocele Repair
Charles F. Palmer, MD; Rodney J. Schlosser, MDCharles F. Palmer, MD; Rodney J. Schlosser, MD - Imaging & Testing
Practical MRI in Neurology: Use Cases, Technologies, and Opportunities for Outpatient Clinics
Joseph Fritz, PhD; Edmond A. Knopp, MD, DABR, FASFNRJoseph Fritz, PhD; Edmond A. Knopp, MD, DABR, FASFNR - Alzheimer Disease & Dementias
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
- Movement Disorders
Understanding Dystonia: A Practical Approach to Diagnosis and Management
Tiziana De Santis, MD; Steven J. Frucht, MDTiziana De Santis, MD; Steven J. Frucht, MD
